- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
GE, Applicare in discussions
GE, Applicare in discussionsA rumor working its way through the PACS grapevine has GE Medical Systems about to acquire Dutch PACS software developer Applicare Medical Imaging. A GE representative would say only that discussions about a
GE, Applicare in discussions
A rumor working its way through the PACS grapevine has GE Medical Systems about to acquire Dutch PACS software developer Applicare Medical Imaging. A GE representative would say only that discussions about a relationship between the two companies have taken place.
Applicare CEO Ruud Kroon also confirmed that discussions on cooperation have occurred, as part of "normal and ongoing efforts on both sides in a consolidating marketplace to improve market positions and product portfolios." The two firms held similar talks in 1997.
Applicare sells its RadWorks product line through various channels, including distributors and OEM partners. That approach has been successful for the company and has provided a valuable source of customer feedback, Kroon said.
"All of our business partners can be assured that continuation of this policy and their long-term access to RadWorks technology is considered to be a vital company interest," he said.
- Search again
- Homepage
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
